Patent · US Active

Compounds as PDE IV and TNF inhibitors

US7652144B2 · kind B2 · utility

4Cited by
13References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 18, 2007
Grant dateJan 26, 2010
Priority date—
Expiry dateJun 18, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2603/66
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound of formula XIXwherein R1, R2, Z1, Z2, Q1, Q2 and Q3 as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.